Huws Gray Group Streamlines IT Operations Across 335 Locations, Saving 40+ Hours Monthly with ControlUp ONE Platform
LONDON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- ControlUp, a global leader in…
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
September 30, 2025 17:25 ET | Source: YD Bio Limited TAIWAN, Sept.…
The Beauty Health Company Names Pedro Malha President and Chief Executive Officer
Global Healthcare and Medical Device Executive with More Than 20 Years of…
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2025 16:24 ET | Source: Pyxis Oncology BOSTON, Sept. 30,…
The Eclipse Foundation Releases the 2025 Jakarta EE Developer Survey Report
The 8th annual report highlights Jakarta EE’s growing momentum, with the platform…
E-GetS Scales User Engagement Across SEA with EngageLabs Omnichannel AppPush & WhatsApp Business Solutions
SINGAPORE, Sept. 30, 2025 (GLOBE NEWSWIRE) -- EngageLab, a world-leading AI-powered omnichannel…
Aerospike Database 8.0 Wins 2025 SiliconANGLE TechForward Awards
MOUNTAIN VIEW, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Aerospike, Inc., today…
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
September 29, 2025 19:30 ET | Source: Nxera Pharma Tokyo, Japan and…
Artelo Biosciences Announces Proposed Underwritten Public Offering
September 29, 2025 19:15 ET | Source: Artelo Biosciences SOLANA BEACH, Calif.,…
NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Nave or Resistant R/M-HNSCC
Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients…
